Related Experiment Video
Updated: Feb 15, 2026

Coherence between Brain Cortical Function and Neurocognitive Performance during Changed Gravity Conditions
Published on: May 23, 2011
Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy
Marc B Lande1, Donald L Batisky2, Juan C Kupferman3
1Department of Pediatrics, University of Rochester, Rochester, NY.
Insights
Children with hypertension did not show improved neurocognitive function after one year of treatment compared to controls. Blood pressure control may influence cognitive outcomes in pediatric hypertension.
Area of Science:
- Pediatric Neurology
- Cardiology
- Neuropsychology
Background:
- Primary hypertension in children is a growing concern with potential long-term health implications.
- Hypertension may affect cognitive development and function in pediatric populations.
- Antihypertensive therapy is standard for managing elevated blood pressure.
Purpose of the Study:
- To evaluate neurocognitive test performance changes in children with primary hypertension after initiating antihypertensive therapy.
- To compare cognitive changes in hypertensive children receiving treatment against normotensive controls.
Main Methods:
- A longitudinal study involving children with hypertension and normotensive controls.
- Neurocognitive testing (general intelligence, attention, memory, executive function, processing speed) at baseline and 1-year follow-up.
- Parental rating scales for executive function were also utilized.
Main Results:
- Blood pressure significantly improved in the hypertension group after 1 year of treatment.
- Both hypertensive and control groups showed similar improvements in specific cognitive tests (Rey Auditory Verbal Learning Test, Grooved Pegboard, Delis-Kaplan Executive Function System Tower Test).
- Children with persistent hypertension showed limited cognitive gains, suggesting treatment effectiveness is crucial.
Conclusions:
- Children with primary hypertension did not demonstrate neurocognitive improvements beyond age-related or practice effects after one year of antihypertensive therapy.
- The extent of blood pressure reduction achieved through antihypertensive therapy may be a key factor influencing neurocognitive outcomes in pediatric hypertension.
Objective:
To determine the change in neurocognitive test performance in children with primary hypertension after initiation of antihypertensive therapy.
Study Design:
Subjects with hypertension and normotensive control subjects had neurocognitive testing at baseline and again after 1 year, during which time the subjects with hypertension received antihypertensive therapy. Subjects completed tests of general intelligence, attention, memory, executive function, and processing speed, and parents completed rating scales of executive function.
Results:
Fifty-five subjects with hypertension and 66 normotensive control subjects underwent both baseline and 1-year assessments. Overall, the blood pressure (BP) of subjects with hypertension improved (24-hour systolic BP load: mean baseline vs 1 year, 58% vs 38%, P < .001). Primary multivariable analyses showed that the hypertension group improved in scores of subtests of the Rey Auditory Verbal Learning Test, Grooved Pegboard, and Delis-Kaplan Executive Function System Tower Test (P < .05). However, the control group also improved in the same measures with similar effects sizes. Secondary analyses by effectiveness of antihypertensive therapy showed that subjects with persistent ambulatory hypertension at 1 year (n = 17) did not improve in subtests of Rey Auditory Verbal Learning Test and had limited improvement in Grooved Pegboard.
Conclusions:
Overall, children with hypertension did not improve in neurocognitive test performance after 1 year of antihypertensive therapy, beyond that also seen in normotensive controls, suggesting improvements with age or practice effects because of repeated neurocognitive testing. However, the degree to which antihypertensive therapy improves BP may affect its impact upon neurocognitive function.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of Diuretics

